A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses

Clinical trial NCT06693362 · RECRUITING

Trial details

NCT number: NCT06693362
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Viral Pneumonia(Not Include COVID-19)

Start date: 2025-01-20
Primary completion: 2026-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.